Literature DB >> 17672870

Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

C Ekerfelt1, M Andersson, A Olausson, S Bergström, P Hultman.   

Abstract

Lyme borreliosis is a complex infection, where some individuals develop so-called 'chronic borreliosis'. The pathogenetic mechanisms are unknown, but the type of immune response is probably important for healing. A strong T helper cell type 1 (Th1)-like response has been suggested as crucial for eradication of Borrelia and for avoiding development of chronic disease. Many studies aimed at altering the Th1/Th2 balance in Lyme arthritis employed mice deficient in cytokine genes, but the outcome has not been clear-cut, due possibly to the high redundancy of cytokines. This study aimed at studying the importance of the Th1/Th2 balance in murine Borrelia arthritis by using the Th2-deviating effect of subtoxic doses of inorganic mercury. Ninety-eight C3H/HeN mice were divided into four groups: Borrelia-infected (Bb), Borrelia-infected exposed to HgCl(2) (BbHg), controls exposed to HgCl(2) alone and normal controls. Mice were killed on days 3, 16, 44 and 65 post-Borrelia inoculation. Arthritis severity was evaluated by histology, spirochaetal load determined by Borrelia culture, IgG2a- and IgE-levels analysed by enzyme-linked immunosorbemt assay (ELISA) and cytokine-secreting cells detected by enzyme-linked immunospot (ELISPOT). BbHg mice showed less severe histological arthritis, but delayed eradication of spirochaetes compared to Bb mice, associated with increased levels of IgE (Th2-induced) and decreased levels of IgG2a (Th1-induced), consistent with a Th2-deviation. Both the numbers of Th1 and Th2 cytokine-secreting cells were reduced in BbHg mice, possibly explained by the fact that numbers of cytokine-secreting cells do not correlate with cytokine concentration. In conclusion, this study supports the hypothesis that a Th1-like response is required for optimal eradication of Borrelia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17672870      PMCID: PMC2219278          DOI: 10.1111/j.1365-2249.2007.03474.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  61 in total

1.  Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.

Authors:  V Preac-Mursic; K Weber; H W Pfister; B Wilske; B Gross; A Baumann; J Prokop
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 2.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis.

Authors:  M Grusell; M Widhe; C Ekerfelt
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

Review 4.  IL-13 effector functions.

Authors:  Thomas A Wynn
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  Dose-response study of thimerosal-induced murine systemic autoimmunity.

Authors:  S Havarinasab; L Lambertsson; J Qvarnström; P Hultman
Journal:  Toxicol Appl Pharmacol       Date:  2004-01-15       Impact factor: 4.219

Review 6.  Lyme borreliosis.

Authors:  Gerold Stanek; Franc Strle
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

7.  The genotype determines the B cell response in mercury-treated mice.

Authors:  U Johansson; H Hansson-Georgiadis; P Hultman
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

8.  Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.

Authors:  Mona Widhe; Sara Jarefors; Christina Ekerfelt; Magnus Vrethem; Sven Bergstrom; Pia Forsberg; Jan Ernerudh
Journal:  J Infect Dis       Date:  2004-04-26       Impact factor: 5.226

9.  Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.

Authors:  John A Christopherson; Erik L Munson; Douglas M England; Cindy L Croke; Monica C Remington; Melanie L Molitor; David J DeCoster; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain.

Authors:  Guiqing Wang; Caroline Ojaimi; Hongyan Wu; Victoria Saksenberg; Radha Iyer; Dionysios Liveris; Steve A McClain; Gary P Wormser; Ira Schwartz
Journal:  J Infect Dis       Date:  2002-08-20       Impact factor: 5.226

View more
  4 in total

1.  Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans.

Authors:  Johanna Sjöwall; Linda Fryland; Marika Nordberg; Florence Sjögren; Ulf Garpmo; Christian Jansson; Sten-Anders Carlsson; Sven Bergström; Jan Ernerudh; Dag Nyman; Pia Forsberg; Christina Ekerfelt
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 2.  Lyme disease: a review.

Authors:  Adriana R Marques
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.919

3.  Repeated Exposition to Mercury (II) Chloride Enhances Susceptibility to S. schenckii sensu stricto Infection in Mice.

Authors:  Alexander Batista-Duharte; Damiana Téllez-Martínez; Juliana Aparecida Jellmayer; Deivys Leandro Portuondo Fuentes; Marisa Campos Polesi; Amanda Martins Baviera; Iracilda Zeppone Carlos
Journal:  J Fungi (Basel)       Date:  2018-05-25

4.  Interferon alpha inhibits antigen-specific production of proinflammatory cytokines and enhances antigen-specific transforming growth factor beta production in antigen-induced arthritis.

Authors:  Jaya Chalise; Sudeep Narendra; Bhesh Paudyal; Mattias Magnusson
Journal:  Arthritis Res Ther       Date:  2013-10-03       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.